US2016137750A1PendingUtilityA1

Method of treating a pathological syndrome

49
Assignee: EPSHTEIN OLEG IIIICHPriority: Jun 20, 2000Filed: Jan 22, 2016Published: May 19, 2016
Est. expiryJun 20, 2020(expired)· nominal 20-yr term from priority
Inventors:Oleg Iiiich Epshtein
A61P 3/04A61P 9/10A61P 37/00A61P 43/00A61P 9/00A61P 31/00A61P 31/12A61K 2039/505C07K 16/249C07K 16/245C07K 16/00C07K 16/22A61P 25/30C07K 16/44A61P 25/24A61K 41/0004C07K 16/2806A61P 3/10A61P 25/32C07K 16/26C07K 2317/75A61K 2039/545C07K 2317/77C07K 16/248A61K 39/39583C07K 16/28C07K 16/243A61P 29/00C07K 16/24A61P 25/36C07K 16/246A61P 25/34C07K 2317/73A61P 25/28C07K 16/241A61P 25/16C07K 16/40A61P 25/18A61K 31/277
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method of treating disorder or condition that relates to intracellular signal transmission of a neurotransmitter, comprising administration of an homeopathically potentized form of antibodies to an antigen, which antigen is a molecule capable of effecting the intracellular signal transmission of a neuroreceptor, in particular dopamine or serotonin.

Claims

exact text as granted — not AI-modified
1 .- 8 . (canceled) 
     
     
         9 . A method of treating a disorder or condition that relates to intracellular signal transmission of serotonin in a patient, said method comprising administering to said patient in need thereof a homeopathically potentized form of an antibody to an antigen, which antigen is a molecule capable of effecting said intracellular signal transmission of serotonin. 
     
     
         10 . The method of  claim 9 , wherein said antigen is an endogenous biomolecule. 
     
     
         11 . The method of  claim 10 , wherein said endogenous biomolecule is serotonin. 
     
     
         12 . The method of  claim 9 , wherein said disorder or condition is depression. 
     
     
         13 .- 19 . (canceled) 
     
     
         20 . A method for administering to a patient suffering from a neuropsychiatric disorder a homeopathically potentized form of at least one antibody to an antigen, which antigen is a molecule capable of treating said neuropsychiatric disorders. 
     
     
         21 . The method of  claim 20 , wherein said potentized form of at least one antibody is produced by homeopathic technology. 
     
     
         22 . The method of  claim 20 , wherein said antibody is a monoclonal, polyclonal, or natural. 
     
     
         23 . The method of  claim 20 , wherein said antigen is an endogenous molecule. 
     
     
         24 .- 26 . (canceled) 
     
     
         27 . The method of  claim 20 , wherein said neuropsychiatric disorder is depression. 
     
     
         28 . (canceled)

Join the waitlist — get patent alerts

Track US2016137750A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.